Curcumin (BCM-95 / Theracurmin) for Stage IV Cancer
Also known as: BCM-95, Theracurmin, Turmeric extract
Curcumin's multi-target anti-cancer mechanisms make it a widely studied adjunctive therapy for cancer treatment.
Mechanism of Action
In cancer, curcumin inhibits NF-κB-driven survival signaling, blocks PI3K/Akt and MAPK proliferation pathways, induces apoptosis through mitochondrial and death receptor pathways, and inhibits angiogenesis by suppressing VEGF. It also sensitizes cancer cells to chemotherapy and radiation.
General mechanism: Polyphenol from turmeric. NF-κB inhibitor, anti-amyloid, antioxidant, PI3K/Akt modulator, HDAC/HAT epigenetic modifier.
Current Evidence
Preclinical evidence across dozens of cancer types. Clinical trials show safety as adjunctive therapy. Some evidence of improved chemotherapy tolerance and response. Bioavailability limitations affect clinical translation.
Clinical Status: Generally recognized as safe. Multiple Phase I/II trials for cancer. Used as adjunctive supplement in integrative oncology.
Safety Profile
Very safe. GI effects at high doses. Poor bioavailability requires enhanced formulations. No significant drug interactions at supplement doses.
Key Research Questions
- Can curcumin enhance checkpoint inhibitor response through NF-κB modulation?
- What formulation achieves optimal tumor tissue concentration?
- Does curcumin reduce chemotherapy side effects while maintaining efficacy?
Frequently Asked Questions
Does curcumin help with Alzheimer's?
Curcumin binds amyloid-beta plaques, inhibits NF-κB inflammation, and reduces tau phosphorylation in preclinical studies. Clinical trials show some biomarker improvements but mixed cognitive outcomes, largely due to poor oral bioavailability. Enhanced formulations (Theracurmin, BCM-95) show better brain penetration.
Curcumin vs turmeric for inflammation
Turmeric contains 2-5% curcumin. Supplemental curcumin provides 500-2000mg of active compound — equivalent to eating 25-100g of turmeric daily. Standardized curcumin extracts with piperine or phospholipid complexes provide 20-30x better absorption than plain turmeric.
Best curcumin supplement for cancer research
Bioavailability-enhanced formulations include Theracurmin (nanoparticle), Meriva (phospholipid complex), BCM-95 (with essential oils), and Longvida (SLCP). For cancer research contexts, Theracurmin and BCM-95 have the most clinical trial data.